Literature DB >> 22156835

Napsin A expression in lung and kidney neoplasia: a review and update.

Nelson G Ordóñez1.   

Abstract

Napsin A is an aspartic protease present in the epithelial cells of the lung and kidney. Recent studies have shown that, in lung tumors, napsin A expression is restricted to lung adenocarcinomas, whereas among renal tumors, it is frequently expressed in renal cell carcinomas, especially the papillary and clear cell subtypes. Owing to its restricted expression, napsin A is a useful marker that can assist in the diagnosis of both lung adenocarcinomas and renal cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22156835     DOI: 10.1097/PAP.0b013e31823e472e

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  8 in total

1.  The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.

Authors:  Yunfan Ma; Mengying Fan; Liang Dai; Xiaozheng Kang; Yiqiang Liu; Yu Sun; Wanpu Yan; Zhen Liang; Hongchao Xiong; Keneng Chen
Journal:  Tumour Biol       Date:  2015-05-16

2.  Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma.

Authors:  David S Tourigny; Mark Zucker; Minsoo Kim; Paul Russo; Jonathan Coleman; Chung-Han Lee; Maria I Carlo; Ying-Bei Chen; A Ari Hakimi; Ritesh R Kotecha; Ed Reznik
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

3.  Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.

Authors:  Yang Qu; Dan Zhao; Jing Mu; Nanying Che; Chen Zhang; Zichen Liu; Dan Su; Lijuan Zhou; Haiqing Zhang; Lixin Wei
Journal:  Tumour Biol       Date:  2015-08-09

4.  Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.

Authors:  Susumu Matsukuma; Takako Kono; Hiroaki Takeo; Yusuke Hamakawa; Kimiya Sato
Journal:  Virchows Arch       Date:  2013-08-03       Impact factor: 4.064

Review 5.  A target safety assessment of the potential toxicological risks of targeting plasmepsin IX/X for the treatment of malaria.

Authors:  Jane Barber; Phumzile Sikakana; Claire Sadler; Delphine Baud; Jean-Pierre Valentin; Ruth Roberts
Journal:  Toxicol Res (Camb)       Date:  2021-02-15       Impact factor: 3.524

6.  Napsin A as a marker of clear cell ovarian carcinoma.

Authors:  Ingiridur Skirnisdottir; Kathrine Bjersand; Helena Akerud; Tomas Seidal
Journal:  BMC Cancer       Date:  2013-11-05       Impact factor: 4.430

7.  Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas.

Authors:  Fatemeh Nili; Mansoureh Tavakoli; Narges Izadi Mood; Hana Saffar; Soheila Sarmadi
Journal:  Iran J Pathol       Date:  2020-02-28

8.  Napsin A Expression in Human Tumors and Normal Tissues.

Authors:  Sören Weidemann; Jan Lukas Böhle; Hendrina Contreras; Andreas M Luebke; Martina Kluth; Franziska Büscheck; Claudia Hube-Magg; Doris Höflmayer; Katharina Möller; Christoph Fraune; Christian Bernreuther; Michael Rink; Ronald Simon; Anne Menz; Andrea Hinsch; Patrick Lebok; Till Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Stefan Steurer; Eike Burandt; Rainer Krech; David Dum; Till Krech; Andreas Marx; Sarah Minner
Journal:  Pathol Oncol Res       Date:  2021-04-20       Impact factor: 3.201

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.